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Ethics of AAL for People 
with Dementia  
Ambient Assisted Living for People with 
Dementia 
Ambient assisted living (AAL) technologies can provide assistance and support 
to vulnerable persons, including those who suffer from dementia. They might 
allow these persons the possibility of living at home for longer whilst still 
maintaining their comfort, safety and security. However, the development, 
introduction and use of AAL technologies also trigger serious ethical issues. 
This presentation will provide an overview of the ongoing scholarly debate 
about these issues. We address the question of what ethical issues are 
involved in the various stages of research and development, clinical 
experimentation, and clinical application of AAL technologies for people with 
dementia (PwD) and other related stakeholders? The presentation will focus 
specifically on the value of the goals of AAL for persons with dementia. 
Why do we need AAL for PwD? 
Due to increased life expectancy and falling birth rates, the age distribution in 
developed countries is gradually shifting towards older populations. This 
evidence points to an unavoidable, worldwide, increase in the age profile for 
humankind and therefore, an increase in the prevalence of age-related 
diseases, including dementia. The ageing population necessitates better and 
more effective healthcare systems and technologies. AAL technologies show 
promise in contributing to a solution to this challenge. 
Why do we need ethical analysis? 
Clinical trials 
The responsible development of AAL technologies demands substantial 
analysis of the ethical issues that might arise during R&D, clinical trials or 
clinical practice. During these stages of development, various claims and 
interests emerge from different stakeholders.  
Literature review 
Only a few literature reviews are available on this topic. We conducted an 
extensive systematic literature review on the ethics of AAL technologies for 
PwD.  
 
Peter Novitzky, Alan F. Smeaton, Cynthia Chen, Kate Irving, 
Tim Jacquemard, Fiachra O’Brolcháin, Dónal O’Mathúna, and 
Bert Gordijn 
Results 
The ethical challenges and opportunities in the scientific literature have been 
categorised according to the stakeholders involved during the various stages of 
development (R&D, clinical trials, clinical application): 
•  PwD 
•  Formal and informal caregivers (nurses, family proxies, etc.) 
•  Researchers and clinicians 
•  Software/hardware engineers 
•  Designers 
•  Technicians 
Various challenges and opportunities were found in the following areas of AAL 
technologies for PwD: independent living, socialisation, empowerment, safety 
and security, care and cost burdens.  
The ethical challenges and opportunities 
An extensive list has been identified of ethical challenges and opportunities 
throughout the literature review (for a complete list, see Novitzky et al., 2014). 
Three main topics of the development of AAL for PwD have been specified that 
need further attention and ethical analysis. 
The value of the goals of AAL 
The value of the goals of AAL technologies has to be carefully assessed in the 
light of issues, such as: 
•  AAL technologies provide only non-therapeutic treatment with all its ethical 
implications 
•  Lax regulation of testing standards for AAL has been reported (Hofmann, 
2012) 
•  The overlapping stakeholders’ motivations for R&D are often conflicting. 
Many articles accept the benefits of AAL without critically questioning this 
presumption. The justification of AAL for PwD is weaker if it provides benefits 
only for the caregivers or third parties instead of primarily the persons in need 
of care. This would violate the ethical principle of proportionality between the 
burdens/harms and benefits of AAL. 
Special vulnerability of PwD 
The special vulnerability of PwD pose challenges for AAL technologies used in 
home environments, where there is a lack of ‘safety nets’ present in healthcare 
institutions. Errors, malfunctions, and usability require very high standards for 
safety, security and reliability of AAL technologies. 
Informed consent 
We propose defining a concept of rolling informed consent during the R&D of 
AAL technologies for PwD. Such an adaptation of the ethical requirement of 
informed consent should consider the special needs of PwD, while actively 
engaging them in the R&D of AAL technologies. 
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